SA
APYX icon

Strategic Advisors’s Apyx Medical APYX Stock Holding History

Strategic Advisors’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19,430
Closed -$26.6K – 178
2025
Q1 		$26.6K Buy
+19,430
New +$26.8K 0.01% 187

Other funds holding APYX

Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $211M AUM 58.81% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Horizon Kinetics Asset Management
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Strategic Advisors's APYX Position: Q2 2025 in Review

Strategic Advisors sold out of Apyx Medical (APYX) in Q2 2025, closing a stake of 19,430 shares — an estimated $26.6K sold.

Strategic Advisors first reported a position in APYX in Q1 2025 and held it in 1 quarter. The position peaked at $26.6K in Q1 2025. 39 funds tracked by Wall St. Rank hold APYX as of Q2 2025.

  • Strategic Advisors reported no remaining Apyx Medical position as of Q2 2025 after selling out during the quarter.
  • Strategic Advisors sold 19,430 Apyx Medical shares in Q2 2025, an estimated $26.6K.
  • Strategic Advisors first reported a position in Apyx Medical in Q1 2025 and held it in 1 quarter.
  • Strategic Advisors's Apyx Medical position peaked at $26.6K in Q1 2025.
  • 39 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2025.

Based on Strategic Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.